Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Bypass | 24 | 2021 | 297 | 1.830 |
Why?
|
Education, Medical, Graduate | 3 | 2017 | 341 | 0.960 |
Why?
|
Chronic Pain | 3 | 2022 | 150 | 0.930 |
Why?
|
Virtual Reality | 2 | 2021 | 15 | 0.890 |
Why?
|
Personal Satisfaction | 2 | 2014 | 81 | 0.860 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2014 | 73 | 0.860 |
Why?
|
Coronary Artery Disease | 9 | 2020 | 308 | 0.860 |
Why?
|
Parents | 3 | 2018 | 381 | 0.780 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 118 | 0.750 |
Why?
|
Thoracic Surgery | 5 | 2005 | 70 | 0.720 |
Why?
|
Specialty Boards | 2 | 2017 | 14 | 0.710 |
Why?
|
Hospitals, Teaching | 2 | 2017 | 104 | 0.680 |
Why?
|
Nurses, Pediatric | 1 | 2020 | 6 | 0.670 |
Why?
|
Compassion Fatigue | 1 | 2020 | 13 | 0.660 |
Why?
|
Computer-Assisted Instruction | 3 | 2005 | 79 | 0.640 |
Why?
|
Training Support | 2 | 2017 | 20 | 0.630 |
Why?
|
Postoperative Complications | 11 | 2020 | 1284 | 0.620 |
Why?
|
Child | 12 | 2022 | 4436 | 0.620 |
Why?
|
Burnout, Professional | 1 | 2020 | 133 | 0.570 |
Why?
|
Educational Measurement | 3 | 2016 | 216 | 0.570 |
Why?
|
Mucopolysaccharidoses | 2 | 2019 | 4 | 0.570 |
Why?
|
Accreditation | 1 | 2017 | 76 | 0.550 |
Why?
|
New York | 21 | 2020 | 144 | 0.550 |
Why?
|
Certification | 1 | 2016 | 50 | 0.520 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 96 | 0.500 |
Why?
|
Humans | 66 | 2023 | 62651 | 0.490 |
Why?
|
Financial Management | 1 | 2015 | 6 | 0.490 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 397 | 0.480 |
Why?
|
Quality of Life | 4 | 2022 | 1221 | 0.480 |
Why?
|
Registries | 13 | 2020 | 872 | 0.460 |
Why?
|
Anxiety | 4 | 2022 | 421 | 0.450 |
Why?
|
Drug-Eluting Stents | 4 | 2020 | 62 | 0.440 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 155 | 0.440 |
Why?
|
CD-ROM | 2 | 2004 | 4 | 0.430 |
Why?
|
Caregivers | 2 | 2014 | 268 | 0.430 |
Why?
|
Cardiac Surgical Procedures | 4 | 2020 | 263 | 0.430 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2018 | 170 | 0.420 |
Why?
|
Internship and Residency | 4 | 2017 | 787 | 0.410 |
Why?
|
Female | 43 | 2022 | 32478 | 0.410 |
Why?
|
Curriculum | 3 | 2005 | 585 | 0.390 |
Why?
|
Percutaneous Coronary Intervention | 3 | 2020 | 206 | 0.380 |
Why?
|
Male | 41 | 2022 | 29469 | 0.380 |
Why?
|
Angioplasty, Balloon, Coronary | 6 | 2012 | 168 | 0.380 |
Why?
|
Internet | 3 | 2005 | 463 | 0.380 |
Why?
|
Risk Factors | 25 | 2021 | 5302 | 0.370 |
Why?
|
Clinical Competence | 1 | 2016 | 713 | 0.370 |
Why?
|
Adolescent | 10 | 2022 | 6165 | 0.360 |
Why?
|
Mass Screening | 1 | 2017 | 686 | 0.360 |
Why?
|
Hospital Mortality | 13 | 2021 | 865 | 0.360 |
Why?
|
Decision Making | 1 | 2014 | 402 | 0.350 |
Why?
|
Risk Assessment | 12 | 2020 | 2039 | 0.340 |
Why?
|
Mitral Valve | 2 | 2018 | 116 | 0.340 |
Why?
|
Critical Illness | 1 | 2013 | 321 | 0.340 |
Why?
|
Mental Disorders | 1 | 2017 | 756 | 0.320 |
Why?
|
Coronary Disease | 5 | 2013 | 246 | 0.320 |
Why?
|
Practice Patterns, Physicians' | 5 | 2018 | 707 | 0.310 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 1069 | 0.300 |
Why?
|
United States | 10 | 2021 | 7721 | 0.300 |
Why?
|
Time Factors | 16 | 2020 | 3740 | 0.280 |
Why?
|
Heart Valve Prosthesis | 2 | 2009 | 109 | 0.260 |
Why?
|
Aortic Valve Stenosis | 3 | 2016 | 188 | 0.260 |
Why?
|
Physician Executives | 1 | 2005 | 28 | 0.240 |
Why?
|
Treatment Outcome | 16 | 2023 | 5584 | 0.230 |
Why?
|
Retrospective Studies | 15 | 2021 | 6528 | 0.230 |
Why?
|
Funnel Chest | 1 | 2004 | 7 | 0.230 |
Why?
|
Child, Preschool | 6 | 2020 | 1932 | 0.220 |
Why?
|
Surgical Mesh | 1 | 2004 | 61 | 0.220 |
Why?
|
Prostheses and Implants | 1 | 2004 | 71 | 0.220 |
Why?
|
Cardiac Catheterization | 3 | 2016 | 279 | 0.220 |
Why?
|
Aortic Valve | 2 | 2016 | 189 | 0.210 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2004 | 20 | 0.210 |
Why?
|
Tricuspid Valve | 1 | 2004 | 25 | 0.210 |
Why?
|
HIV-1 | 3 | 2007 | 716 | 0.210 |
Why?
|
Enzyme Replacement Therapy | 3 | 2019 | 12 | 0.210 |
Why?
|
Adenoidectomy | 2 | 2020 | 7 | 0.210 |
Why?
|
Tonsillectomy | 2 | 2020 | 11 | 0.210 |
Why?
|
Middle Aged | 27 | 2020 | 17358 | 0.210 |
Why?
|
Aged | 25 | 2020 | 14249 | 0.200 |
Why?
|
Coronary Vessels | 2 | 2020 | 118 | 0.200 |
Why?
|
Biofeedback, Psychology | 1 | 2022 | 6 | 0.200 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 75 | 0.200 |
Why?
|
Hospitalization | 3 | 2019 | 1344 | 0.200 |
Why?
|
Neonatal Screening | 1 | 2022 | 97 | 0.190 |
Why?
|
Guideline Adherence | 2 | 2018 | 306 | 0.190 |
Why?
|
Patient Readmission | 3 | 2021 | 429 | 0.190 |
Why?
|
Mortality | 2 | 2020 | 160 | 0.190 |
Why?
|
Aged, 80 and over | 16 | 2020 | 5403 | 0.190 |
Why?
|
Practice Guidelines as Topic | 3 | 2018 | 725 | 0.190 |
Why?
|
Radiography, Thoracic | 1 | 2002 | 116 | 0.180 |
Why?
|
Medical Marijuana | 1 | 2021 | 18 | 0.180 |
Why?
|
Artificial Intelligence | 1 | 2023 | 163 | 0.180 |
Why?
|
Technology | 1 | 2021 | 52 | 0.180 |
Why?
|
Infant, Newborn | 2 | 2022 | 1338 | 0.180 |
Why?
|
Pain Management | 2 | 2021 | 163 | 0.180 |
Why?
|
Prognosis | 3 | 2022 | 1724 | 0.180 |
Why?
|
Anesthesiologists | 1 | 2020 | 18 | 0.170 |
Why?
|
Heart Rate | 1 | 2022 | 319 | 0.170 |
Why?
|
Lung Diseases | 1 | 2002 | 175 | 0.170 |
Why?
|
Patient Handoff | 1 | 2020 | 35 | 0.170 |
Why?
|
Cannabis | 1 | 2021 | 51 | 0.170 |
Why?
|
Child Behavior | 1 | 2020 | 64 | 0.160 |
Why?
|
Chondroitinsulfatases | 1 | 2019 | 1 | 0.160 |
Why?
|
Mucopolysaccharidosis IV | 1 | 2019 | 1 | 0.160 |
Why?
|
Reoperation | 2 | 2019 | 290 | 0.160 |
Why?
|
Reproducibility of Results | 2 | 2014 | 1638 | 0.160 |
Why?
|
Surveys and Questionnaires | 3 | 2020 | 2646 | 0.160 |
Why?
|
Anxiety Disorders | 1 | 2021 | 192 | 0.160 |
Why?
|
Ventricular Dysfunction | 1 | 2019 | 13 | 0.160 |
Why?
|
Coronary Artery Bypass, Off-Pump | 2 | 2010 | 5 | 0.160 |
Why?
|
Feasibility Studies | 1 | 2021 | 562 | 0.150 |
Why?
|
Forecasting | 2 | 2017 | 230 | 0.150 |
Why?
|
Pilot Projects | 1 | 2022 | 985 | 0.150 |
Why?
|
Follow-Up Studies | 9 | 2020 | 2445 | 0.150 |
Why?
|
Analgesics | 1 | 2019 | 102 | 0.150 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2018 | 19 | 0.150 |
Why?
|
Pain, Postoperative | 1 | 2020 | 161 | 0.150 |
Why?
|
Intensive Care Units | 2 | 2020 | 405 | 0.150 |
Why?
|
Anesthesia, General | 1 | 2018 | 45 | 0.150 |
Why?
|
Heart Defects, Congenital | 1 | 2019 | 100 | 0.140 |
Why?
|
Models, Statistical | 2 | 2012 | 307 | 0.140 |
Why?
|
Communication Barriers | 1 | 2018 | 62 | 0.140 |
Why?
|
Perioperative Care | 1 | 2018 | 85 | 0.140 |
Why?
|
Pain | 2 | 2021 | 406 | 0.140 |
Why?
|
Organizational Objectives | 1 | 2017 | 58 | 0.140 |
Why?
|
Capital Financing | 1 | 2017 | 5 | 0.140 |
Why?
|
Mitral Valve Insufficiency | 1 | 2018 | 81 | 0.140 |
Why?
|
Heart Failure | 2 | 2019 | 900 | 0.140 |
Why?
|
Tuberculosis, Pulmonary | 3 | 2007 | 111 | 0.140 |
Why?
|
Disease Management | 1 | 2019 | 234 | 0.140 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 116 | 0.140 |
Why?
|
Heart Diseases | 1 | 2019 | 215 | 0.140 |
Why?
|
Adult | 9 | 2020 | 16620 | 0.130 |
Why?
|
Advisory Committees | 1 | 2017 | 112 | 0.130 |
Why?
|
American Medical Association | 1 | 2016 | 6 | 0.130 |
Why?
|
Domestic Violence | 1 | 2017 | 39 | 0.130 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 268 | 0.130 |
Why?
|
Pediatricians | 1 | 2017 | 50 | 0.130 |
Why?
|
Universities | 1 | 2017 | 157 | 0.130 |
Why?
|
Fatigue | 1 | 2016 | 112 | 0.120 |
Why?
|
Medically Underserved Area | 1 | 2015 | 28 | 0.120 |
Why?
|
Patient Satisfaction | 1 | 2018 | 431 | 0.120 |
Why?
|
HIV Infections | 1 | 2002 | 962 | 0.120 |
Why?
|
Proportional Hazards Models | 6 | 2016 | 726 | 0.120 |
Why?
|
Stents | 2 | 2011 | 486 | 0.110 |
Why?
|
Medicare | 2 | 2017 | 614 | 0.110 |
Why?
|
Sternum | 2 | 2004 | 29 | 0.110 |
Why?
|
Insurance, Health | 1 | 2015 | 151 | 0.110 |
Why?
|
Cerebrum | 1 | 2014 | 16 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 207 | 0.110 |
Why?
|
Angina Pectoris | 1 | 2013 | 38 | 0.110 |
Why?
|
Myocardial Infarction | 2 | 2019 | 910 | 0.110 |
Why?
|
Young Adult | 3 | 2021 | 4630 | 0.110 |
Why?
|
Electronic Health Records | 1 | 2017 | 355 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2014 | 62 | 0.110 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2015 | 109 | 0.100 |
Why?
|
Mycobacterium tuberculosis | 3 | 2007 | 405 | 0.100 |
Why?
|
Cardiopulmonary Bypass | 2 | 2010 | 56 | 0.100 |
Why?
|
Cognition Disorders | 1 | 2014 | 220 | 0.100 |
Why?
|
Health Surveys | 1 | 2013 | 312 | 0.100 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 583 | 0.100 |
Why?
|
Quality Improvement | 1 | 2016 | 433 | 0.100 |
Why?
|
Exercise Test | 1 | 2013 | 250 | 0.100 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2012 | 17 | 0.090 |
Why?
|
Survival Rate | 5 | 2015 | 839 | 0.090 |
Why?
|
Heart Valve Diseases | 1 | 2013 | 93 | 0.090 |
Why?
|
Medicaid | 1 | 2015 | 359 | 0.090 |
Why?
|
Psychometrics | 1 | 2013 | 377 | 0.090 |
Why?
|
Workload | 2 | 2018 | 121 | 0.090 |
Why?
|
Hospitals | 2 | 2004 | 392 | 0.090 |
Why?
|
Hematocrit | 1 | 2010 | 33 | 0.090 |
Why?
|
Health Care Surveys | 2 | 2017 | 284 | 0.090 |
Why?
|
Healthcare Disparities | 1 | 2014 | 351 | 0.090 |
Why?
|
Quality of Health Care | 1 | 2014 | 517 | 0.090 |
Why?
|
Myocardial Revascularization | 2 | 2008 | 75 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2007 | 93 | 0.080 |
Why?
|
Hypothermia | 1 | 2010 | 17 | 0.080 |
Why?
|
Stroke | 1 | 2019 | 1188 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2011 | 112 | 0.080 |
Why?
|
Quality Indicators, Health Care | 2 | 2011 | 334 | 0.080 |
Why?
|
Fever | 1 | 2010 | 66 | 0.080 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 716 | 0.080 |
Why?
|
Logistic Models | 5 | 2016 | 1273 | 0.070 |
Why?
|
Macrophages, Alveolar | 2 | 2007 | 64 | 0.070 |
Why?
|
Heart Valves | 1 | 2007 | 25 | 0.070 |
Why?
|
Clinical Decision-Making | 2 | 2018 | 160 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2007 | 78 | 0.060 |
Why?
|
Virus Replication | 2 | 2007 | 318 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2007 | 138 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2019 | 1540 | 0.060 |
Why?
|
Prospective Studies | 1 | 2013 | 3258 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 1 | 2007 | 240 | 0.060 |
Why?
|
Postoperative Period | 2 | 2019 | 138 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 2145 | 0.060 |
Why?
|
Chemokines, CX3C | 1 | 2004 | 4 | 0.060 |
Why?
|
Osteotomy | 1 | 2004 | 17 | 0.060 |
Why?
|
Chemokines, CC | 1 | 2004 | 13 | 0.060 |
Why?
|
Receptors, Chemokine | 1 | 2004 | 33 | 0.060 |
Why?
|
Infant | 2 | 2019 | 1594 | 0.060 |
Why?
|
Cartilage | 1 | 2004 | 34 | 0.060 |
Why?
|
California | 2 | 2020 | 174 | 0.060 |
Why?
|
Referral and Consultation | 2 | 2004 | 421 | 0.050 |
Why?
|
Suture Techniques | 1 | 2004 | 98 | 0.050 |
Why?
|
Propensity Score | 2 | 2016 | 154 | 0.050 |
Why?
|
Faculty, Medical | 1 | 2005 | 198 | 0.050 |
Why?
|
Risk Adjustment | 2 | 2019 | 94 | 0.050 |
Why?
|
Survival Analysis | 3 | 2012 | 576 | 0.050 |
Why?
|
Software Design | 1 | 2002 | 28 | 0.050 |
Why?
|
Prevalence | 2 | 2020 | 1345 | 0.050 |
Why?
|
Aneurysm, Infected | 1 | 2002 | 11 | 0.050 |
Why?
|
Lymphoproliferative Disorders | 1 | 2002 | 39 | 0.050 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2002 | 68 | 0.050 |
Why?
|
Los Angeles | 1 | 2021 | 11 | 0.050 |
Why?
|
Databases, Factual | 3 | 2012 | 852 | 0.050 |
Why?
|
Retreatment | 1 | 2020 | 47 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2002 | 111 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 1184 | 0.040 |
Why?
|
Length of Stay | 1 | 2004 | 804 | 0.040 |
Why?
|
Colorado | 1 | 2020 | 21 | 0.040 |
Why?
|
Odds Ratio | 3 | 2011 | 768 | 0.040 |
Why?
|
Hospitals, Pediatric | 1 | 2020 | 50 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 1077 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 370 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2020 | 200 | 0.040 |
Why?
|
Hypercapnia | 1 | 2019 | 9 | 0.040 |
Why?
|
Mucopolysaccharidosis VI | 1 | 2019 | 1 | 0.040 |
Why?
|
N-Acetylgalactosamine-4-Sulfatase | 1 | 2019 | 1 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 775 | 0.040 |
Why?
|
Hypnosis, Anesthetic | 1 | 2018 | 1 | 0.040 |
Why?
|
Motivation | 1 | 2021 | 283 | 0.040 |
Why?
|
Adolescent Behavior | 1 | 2020 | 193 | 0.040 |
Why?
|
Preoperative Period | 1 | 2018 | 69 | 0.040 |
Why?
|
Tuberculosis | 1 | 2002 | 294 | 0.040 |
Why?
|
Consensus | 1 | 2019 | 225 | 0.040 |
Why?
|
Incidence | 2 | 2015 | 1367 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2019 | 294 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2019 | 700 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2018 | 103 | 0.030 |
Why?
|
Recovery of Function | 1 | 2018 | 283 | 0.030 |
Why?
|
Coronary Restenosis | 2 | 2008 | 20 | 0.030 |
Why?
|
Medical History Taking | 1 | 2017 | 67 | 0.030 |
Why?
|
Palliative Care | 1 | 2019 | 226 | 0.030 |
Why?
|
Stroke Volume | 1 | 2018 | 328 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2020 | 1247 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 348 | 0.030 |
Why?
|
Surgeons | 1 | 2018 | 180 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2002 | 658 | 0.030 |
Why?
|
Patient Selection | 1 | 2018 | 482 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2015 | 242 | 0.030 |
Why?
|
Sex Distribution | 1 | 2015 | 252 | 0.030 |
Why?
|
Population Surveillance | 1 | 2015 | 203 | 0.030 |
Why?
|
Basal Ganglia | 1 | 2014 | 34 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2014 | 143 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 49 | 0.030 |
Why?
|
Thalamus | 1 | 2014 | 66 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 2014 | 118 | 0.030 |
Why?
|
Sex Factors | 1 | 2015 | 972 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 389 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2010 | 45 | 0.020 |
Why?
|
American Heart Association | 1 | 2010 | 126 | 0.020 |
Why?
|
Observation | 1 | 2008 | 30 | 0.020 |
Why?
|
Cardiology | 1 | 2010 | 167 | 0.020 |
Why?
|
Time | 1 | 2007 | 30 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2007 | 63 | 0.020 |
Why?
|
Bronchoalveolar Lavage | 1 | 2007 | 16 | 0.020 |
Why?
|
DNA, Viral | 1 | 2007 | 231 | 0.020 |
Why?
|
Biomarkers | 1 | 2010 | 1382 | 0.010 |
Why?
|
Surgery Department, Hospital | 1 | 2004 | 21 | 0.010 |
Why?
|
Receptors, CCR4 | 1 | 2004 | 4 | 0.010 |
Why?
|
Gene Expression | 1 | 2007 | 836 | 0.010 |
Why?
|
Opportunistic Infections | 1 | 2004 | 30 | 0.010 |
Why?
|
Utilization Review | 1 | 2003 | 32 | 0.010 |
Why?
|
Species Specificity | 1 | 2004 | 334 | 0.010 |
Why?
|
Cytokines | 1 | 2007 | 933 | 0.010 |
Why?
|
Up-Regulation | 1 | 2004 | 375 | 0.010 |
Why?
|
Health Services Research | 1 | 2003 | 270 | 0.010 |
Why?
|
Aortic Rupture | 1 | 2002 | 54 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 1594 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2004 | 1108 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 1992 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2004 | 1451 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2004 | 2154 | 0.010 |
Why?
|
Mutation | 1 | 2007 | 2573 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2004 | 1528 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 1611 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2002 | 1586 | 0.010 |
Why?
|